Editorial: Do less, do better? Challenging the concomitant PCI paradigm in TAVR
The coexistence of aortic stenosis (AS) and coronary artery disease (CAD) presents a frequent and complex challenge in structural heart disease management. While transcatheter aortic valve replacement (TAVR) has become the preferred therapy for many patients with symptomatic severe AS, the optimal strategy for managing concomitant CAD—particularly the timing of percutaneous coronary intervention (PCI)—remains unresolved.